These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31306631)

  • 21. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
    Garces-Descovich A; Beker K; Jaramillo-Cardoso A; James Moser A; Mortele KJ
    Abdom Radiol (NY); 2018 Feb; 43(2):314-322. PubMed ID: 29392370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival (superior to 20 years) after pancreaticoduodenectomy for pancreatic duct adenocarcinoma: report of two cases.
    Naseef O; Adham M; Hervieu V; Le Borgne J; Partensky C
    Hepatogastroenterology; 2008; 55(84):1110-1. PubMed ID: 18705340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive intraductal papillary mucinous tumor of the pancreas with simultaneous invasion of the stomach and duodenum.
    Jung IS; Shim CS; Cheon YK; Bhandari S; Cha SW; Moon JH; Cho YD; Kim JH; Kim YS; Lee MS; Kim BS
    Endoscopy; 2004 Feb; 36(2):186-9. PubMed ID: 14765321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multi-Institutional Safety and Feasibility Study Exploring the Use of Hydrogel to Create Spatial Separation between the Pancreas and Duodenum in Patients with Pancreatic Cancer.
    Narang AK; Hong TS; Ding K; Herman J; Meyer J; Thompson E; Bhutani MS; Krishnan K; Casey B; Shin EJ; Koay EJ
    Pract Radiat Oncol; 2024; 14(4):e276-e282. PubMed ID: 38043645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T
    Hepatogastroenterology; 2004; 51(59):1500-3. PubMed ID: 15362786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of Safety and Feasibility of Hydrogel Marking of the Pancreas-Duodenum Interface for Image Guided Radiation Therapy (IGRT) in a Porcine Model: Implications in IGRT for Pancreatic Cancer Patients.
    Rao AD; Shin EJ; Beck SE; Garrett C; Kim SH; Lee NJ; Liapi E; Wong J; Herman J; Narang A; Ding K
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):640-645. PubMed ID: 29680252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment decision making in pancreatic adenocarcinoma: multidisciplinary team discussion with multidetector-row computed tomography.
    Furukawa H; Uesaka K; Boku N
    Arch Surg; 2008 Mar; 143(3):275-80; discussion 281. PubMed ID: 18347275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal: Intraductal papillary mucinous neoplasm of the pancreas: Radiologic-pathologic correlation.
    Courcoutsakis N; Karayiannakis A; Astrinakis E; Bolanaki H; Prassopoulos P
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1511. PubMed ID: 27043464
    [No Abstract]   [Full Text] [Related]  

  • 31. Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies.
    Sangalli G; Passoni P; Cattaneo GM; Broggi S; Bettinardi V; Reni M; Slim N; Muzio ND; Calandrino R
    Acta Oncol; 2011 Jan; 50(1):72-80. PubMed ID: 20482224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
    Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
    Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma.
    Schwarz L; Katz MH
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):727-40. PubMed ID: 26226907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning.
    Zaky AM; Wolfgang CL; Weiss MJ; Javed AA; Fishman EK; Zaheer A
    Radiographics; 2017; 37(1):93-112. PubMed ID: 27885893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.
    Toesca DAS; Pollom EL; Poullos PD; Flynt L; Cui Y; Quon A; von Eyben R; Koong AC; Chang DT
    Pract Radiat Oncol; 2017; 7(2):120-125. PubMed ID: 28274396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.
    Bournet B; Pointreau A; Souque A; Oumouhou N; Muscari F; Lepage B; Senesse P; Barthet M; Lesavre N; Hammel P; Levy P; Ruszniewski P; Cordelier P; Buscail L
    Pancreatology; 2012; 12(1):27-34. PubMed ID: 22487470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What the heck is this new periductal hypoechoic sign?
    Affronti J
    Gastrointest Endosc; 2010 Feb; 71(2):256-9. PubMed ID: 20152307
    [No Abstract]   [Full Text] [Related]  

  • 38. Preoperative defining system for pancreatic head cancer considering surgical resection.
    Yang SJ; Hwang HK; Kang CM; Lee WJ
    World J Gastroenterol; 2016 Jul; 22(26):6076-82. PubMed ID: 27468199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
    Bowman AW; Bolan CW
    Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-Friendly Summary of the ACR Appropriateness Criteria: Staging of Pancreatic Ductal Adenocarcinoma.
    Rybicki FJ; Lalani T
    J Am Coll Radiol; 2019 Apr; 16(4 Pt A):e15. PubMed ID: 30947954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.